Weight Loss Pill Ingredient SNAC Raises Concerns Over Gut Health and Inflammation

Recent research from Adelaide University has sparked a debate about the potential side effects of salcaprozate sodium (SNAC), a key ingredient in oral semaglutide medications like Wegovy and Ozempic. Even as SNAC is crucial for enabling the drug to be effectively absorbed in pill form, scientists are urging caution as studies suggest it may have broader biological effects on gut health and systemic inflammation.

What is SNAC and Why is it Used?

Semaglutide, the active ingredient in weight loss drugs Wegovy and Ozempic, is typically administered via injection, allowing direct entry into the bloodstream. However, when formulated as a pill, semaglutide requires assistance to navigate the harsh environment of the stomach and effectively enter the circulation. SNAC acts as an “absorption enhancer,” protecting the drug from enzymatic breakdown and facilitating its passage into the bloodstream. Without SNAC, oral semaglutide would be ineffective.

The Adelaide University Study: What Did Researchers Find?

A study published in the Journal of Controlled Release in April 2026, examined the effects of SNAC, semaglutide, and a combination of both on gut microbiota and metabolic function in healthy rats over 21 days. Researchers observed several significant changes in the animals treated with SNAC:

• Reduced Beneficial Gut Bacteria: SNAC significantly depleted populations of Muribaculaceae (-62%) and Bacteroidaceae (-77%), key primary fermenters in the gut.
• Lower Short-Chain Fatty Acids (SCFAs): The reduction in beneficial bacteria correlated with decreased levels of fecal butyrate (-77% SNAC, -75% SEM-SNAC), critical compounds that support gut health and reduce inflammation.
• Increased Inflammation: Plasma cytokine analysis revealed elevated levels of tumor necrosis factor-α (TNF-α, 70%), an inflammatory marker.
• Potential Cognitive Impacts: Researchers noted suppressed levels of brain-derived neurotrophic factor (BDNF, 85%), a protein linked to cognitive function.
• Organ Changes: SNAC-treated animals exhibited increased liver weight and reduced caecum mass, potentially indicating inflammation and altered gut function.

What Does This Mean for Humans?

While the study was conducted on rats, the findings raise concerns about the potential impact of long-term SNAC exposure in humans, particularly as oral semaglutide becomes more widely used. Lead author Amin Ariaee emphasized the importance of understanding the effects of all ingredients in these medications, not just the active drug. “As oral versions become more widely used, we need to understand what repeated, long-term exposure to all ingredients in the pill means for the body,” he stated.

Obesity Trends and Rising Medication Use

The increasing prevalence of obesity globally – affecting roughly one in eight people worldwide, with particularly high rates in the United States and Australia – is driving the demand for effective weight loss treatments. Prescriptions for medications like Ozempic and Wegovy have been steadily climbing, making a thorough understanding of their components even more critical.

The Need for Further Research

Researchers at Adelaide University acknowledge that their findings do not definitively prove SNAC is harmful to humans. However, they stress the importance of further investigation to fully evaluate the potential long-term effects of this absorption enhancer on gut health, inflammation, and overall well-being. Senior Research Fellow Dr. Paul Joyce noted, “These medicines are typically taken daily and often for long periods. As their use expands globally, it becomes increasingly important to evaluate all components of these therapies, not just the active compound.”

Key Takeaways

• SNAC is essential for the oral delivery of semaglutide, but may have unintended consequences.
• Studies in rats suggest SNAC can disrupt gut microbiota, increase inflammation, and potentially impact cognitive function.
• More research is needed to determine the long-term effects of SNAC in humans.
• As oral semaglutide becomes more popular, understanding the impact of all ingredients is crucial.